Check-Cap Ltd. Share Price Deutsche Boerse AG

Equities

7CC

IL0011336851

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG 08:24:09 28/06/2024 BST 5-day change 1st Jan Change
1.79 EUR -4.79% Intraday chart for Check-Cap Ltd. -12.25% -7.25%

Financials

Sales 2022 - Sales 2023 - Capitalization 12.17M 11.36M 962M
Net income 2022 -19M -17.74M -1.5B Net income 2023 -17M -15.87M -1.34B EV / Sales 2022 -
Net cash position 2022 40.74M 38.04M 3.22B Net cash position 2023 24.77M 23.12M 1.96B EV / Sales 2023 -
P/E ratio 2022
-0.65 x
P/E ratio 2023
-0.69 x
Employees 85
Yield 2022 *
-
Yield 2023
-
Free-Float 74.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.79%
1 week-12.25%
Current month-13.94%
1 month-11.39%
3 months-31.68%
6 months-7.25%
Current year-7.25%
More quotes
1 week
1.79
Extreme 1.79
1.96
1 month
1.79
Extreme 1.79
2.08
Current year
1.67
Extreme 1.67
2.98
1 year
1.67
Extreme 1.67
4.24
3 years
0.23
Extreme 0.2305
21.60
5 years
0.23
Extreme 0.2305
66.00
10 years
0.23
Extreme 0.2305
1 208.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 03-16
Founder 63 31/12/04
Director of Finance/CFO 54 03-05
Members of the board TitleAgeSince
Founder 63 31/12/04
More insiders
Date Price Change
28/06/24 1.79 -4.79%
27/06/24 1.88 +3.30%
26/06/24 1.82 -5.70%
25/06/24 1.93 -1.53%
24/06/24 1.96 -3.92%

Delayed Quote Deutsche Boerse AG, June 28, 2024 at 08:24 am

More quotes
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
More about the company